Safety and efficacy of pociredir in adults with severe sickle cell disease and hydroxyurea intolerance or unresponsiveness: results from the phase 1b PIONEER study
2026Journal of sickle cell disease.JournalOpen access
10.1093/jscdis/yoag020.009Full text0 citations